Open access · CC-BY
via OpenAlex
Parkinson's disease induced pluripotent stem cells with triplication of the α-synuclein locus
Michael J. Devine, Mina Ryten, Petr Vodička, Alison J. Thomson, Tom Burdon, Henry Houlden, Fatima M. Cavaleri, Masumi Nagano, Nicola J. Drummond, Jan‐Willem Taanman, Anthony H.V. Schapira, Katrina A. Gwinn, John Hardy, Patrick Alfryn Lewis, Tilo Kunath
Nature Communications · 2011 · ▲ 486 citations
Abstract
A major barrier to research on Parkinson's disease is inaccessibility of diseased tissue for study. One solution is to derive induced pluripotent stem cells from patients and differentiate them into neurons affected by disease. Triplication of SNCA, encoding α-synuclein, causes a fully penetrant, aggressive form of Parkinson's disease with dementia. α-Synuclein dysfunction is the critical pathogenic event in Parkinson's disease, multiple system atrophy and dementia with Lewy bodies. Here we produce multiple induced pluripotent stem cell lines from an SNCA triplication patient and an unaffected first-degree relative. When these cells are differentiated into midbrain dopaminergic neurons, those from the patient produce double the amount of α-synuclein protein as neurons from the unaffected relative, precisely recapitulating the cause of Parkinson's disease in these individuals. This model represents a new experimental system to identify compounds that reduce levels of α-synuclein, and to investigate the mechanistic basis of neurodegeneration caused by α-synuclein dysfunction. Pluripotent stem cells can be generated from the somatic cells of humans and are a useful model to study disease. Here, pluripotent stem cells are made from a patient with familial Parkinson's disease, and the resulting neurons exhibit elevated levels of α-synuclein, recapitulating the molecular features of the patient's disease.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1038/ncomms1453
- Canonical
- link ↗
- Fetched
- 2026-10-20 MST
Cite this
APA
Devine, M.J., Ryten, M., Vodička, P., Thomson, A.J., Burdon, T., Houlden, H., Cavaleri, F.M., Nagano, M., Drummond, N.J., Taanman, J., Schapira, A.H., Gwinn, K.A., Hardy, J., Lewis, P.A., & Kunath, T. (2011). Parkinson's disease induced pluripotent stem cells with triplication of the α-synuclein locus. <em>Nature Communications</em>. https://doi.org/10.1038/ncomms1453
Vancouver
Devine MJ, Ryten M, Vodička P, Thomson AJ, Burdon T, Houlden H, et al. Parkinson's disease induced pluripotent stem cells with triplication of the α-synuclein locus. Nature Communications. 2011. doi:10.1038/ncomms1453.
BibTeX
@article{michael2011Parkin,
title = {Parkinson's disease induced pluripotent stem cells with triplication of the α-synuclein locus},
author = {Michael J. Devine and Mina Ryten and Petr Vodička and Alison J. Thomson and Tom Burdon and Henry Houlden and Fatima M. Cavaleri and Masumi Nagano and Nicola J. Drummond and Jan‐Willem Taanman and Anthony H.V. Schapira and Katrina A. Gwinn and John Hardy and Patrick Alfryn Lewis and Tilo Kunath},
journal = {Nature Communications},
year = {2011},
doi = {10.1038/ncomms1453},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Handbook of clinical neurology 2022
Preprint · OA
T cells, α-synuclein and Parkinson disease
Molecular Neurobiology 2013
Open access · OA
α-Synuclein and Mitochondrial Dysfunction in Parkinson’s Disease
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2011
Open access · OA
α-Synuclein misfolding and Parkinson's disease
Journal of Neural Transmission 2006
Preprint · CC-BY
The plasma alpha-synuclein levels in patients with Parkinson’s disease and multiple system atrophy
The Lancet 2004
Citation only
α-synuclein locus duplication as a cause of familial Parkinson's disease
Acta Neuropathologica 2007
Citation only